-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Immunocore Holdings plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2024.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $1.06M, a 197% increase year-over-year.
- Immunocore Holdings plc Income Tax Expense (Benefit) for the twelve months ending March 31, 2025 was -$1.15M, a 79.3% increase year-over-year.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2024 was -$1.85M, a 67% increase from 2023.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2023 was -$5.6M, a 148% decline from 2022.
- Immunocore Holdings plc annual Income Tax Expense (Benefit) for 2022 was $11.7M, a 7673% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)